Two-component systems (TCSs) play key roles in the adaptation of bacteria to environmental changes. In prototype TCSs a single phosphoryl transfer between the sensor kinase and response regulator occurs, whereas phosphorelay TCSs are characterised by a His1 -Asp1 -His2 -Asp2 phosphorylation cascade. The TodS/TodT TCS controls the expression of a toluene degradation pathway and the TodS sensor kinase operates by a threestep internal phosphorelay. Based on TodS we report the construction of a minimal form of TodS, termed as MinTodS, that contains only three of the seven TodS domains. Min-TodS is composed of the N-terminal PAS sensor domain as well as the C-terminal dimerisation/ phosphotransfer domain and catalytic domain of TodS. We have conducted a comparative analysis of the phosphorelay TCS with its prototypal derivative. We demonstrate that Min-TodS binds effector molecules with affinities comparable with those observed for TodS. MinTodS forms a TCS with TodT and toluene increases the amount of TodT-P. In contrast to TodS, toluene does not stimulate Min-TodS autophosphorylation. The half-life of Min-TodS-P was significantly increased as compared with TodS. Analysis of TodSD500A revealed that the hydrolysis of the acylphosphate of the receiver domain is responsible for the reduced half-life of TodS. The regulation of P todX expression by Min-TodS/TodT and TodS/TodT in response to different effectors are compared. The MinTodS/TodT system was characterized by a higher basal activity but a lower magnitude of response. Data will be discussed in the context that the phosphorelay system appears to be better suited for the control of a degradation pathway for toxic compounds.
Introduction
Bacteria have to constantly adapt to changes in the environment to guarantee survival. An important mechanism by which bacteria sense environmental signals is through the action of two-component systems (TCSs) that contain a sensor kinase (SK) and a response regulator (RR) as basic elements. Bacteria contain a large number of TCSs and were found to harbour on average 52 TCS genes (Cock and Whitworth, 2007) . TCSs are involved in the regulation of virtually all types of processes including virulence, sporulation, metabolism, quorum sensing, chemotaxis, transport or nitrogen fixation (reviewed in Mascher et al., 2006; Krell et al., 2010) .
Within the family of TCSs, prototype and phosphorelay systems can be distinguished. Typically, a prototype SK is composed of a sensor domain and an autokinase (AK) module. This module is composed of a dimerisation and phosphotransfer domain (DHp) that harbours the phosphorylaccepting histidine residue and a catalytic domain (CA) to which ATP binds and which catalyses the phosphorylation of the histidine residue. The phosphorylated SK donates phosphoryl groups to the RR receiver domain, which in turn alters the functional properties of the RR output domain. This domain often possesses DNA-binding activity and alters gene expression by binding to promoter regions. Other RR output domains exert their activity by binding to proteins or possess enzymatic activities (Galperin, 2010) .
Apart from the SK -RR phosphotransfer activity, the majority of SKs possess kinase as well as phosphatase activities towards the RR (reviewed by Huynh and Stewart, 2011) Well-studied examples of SKs with dual-kinase/phosphatase activity are RcsB (Majdalani and Gottesman, 2005; Fredericks et al., 2006) , DesK (Albanesi et al., 2009) , FixL (Lois et al., 1993) , AbsA1 (Sheeler et al., 2005) or PhoQ (Chamnongpol et al., 2003) . In a number of cases it has been demonstrated that the signal modulates both activities, which is exemplified by the concerted modulation of both activities in FixL or DesK by oxygen or temperature, respectively (Lois et al., 1993; Albanesi et al., 2009) . Only a few SKs have kinase activities only and in those cases auxiliary phosphatases were found to actively dephosphorylate the RR (Huynh and Stewart, 2011) .
Instead of the simple His -Asp transphosphorylation of prototype systems, phosphorelay TCSs use a His1 -Asp1 -His2 -Asp2 phosphorylation cascade (Zhang and Shi, 2005 , Fig. 1 ). His1 forms part of an AK module and Asp1 and Asp2 are present on receiver domains. Genome analyses (Williams and Whitworth, 2010) indicate that there might be two major classes of phosphorelay systems depending on whether His2 forms part of a histidine-containing phosphotransfer domain (systems termed as TRPR) or part of a second AK module (systems termed as TRTR). Phosphorelay systems of the TRPR family have been characterised extensively and representative examples are the ArcBA, TorSR and EvgSA systems of Escherichia coli (Perraud et al., 1999; Malpica et al., 2006) , the BvgST system of Bordetella sp. (Beier and Gross, 2008) or the sporulation phosphorelay of Bacillus subtilis (Burbulys et al., 1991) . Although the genetic abundance of TRPR and TRTR systems is similar (Williams and Whitworth, 2010) , the wealth of information available on TRPR systems contrasts with the scarceness of data on the TRTR systems.
Work in our laboratory on the TodS/TodT system has led to the first functional characterisation of a TRTR-type phosphorelay (Lacal et al., 2006; Busch et al., 2007 Busch et al., , 2009 ). The TodS/ TodT TCS modulates the expression of the tod (toluene dioxygenase) operon (Lau et al., 1997) , which encodes the enzymes of the TOD pathway that permits the mineralisation of benzene, toluene and ethylbenzene in strains of Pseudomonas putida. The tod operon is under control of the promoter P todX (Zylstra and Gibson, 1989; Mosqueda et al., 1999) . Although the TOD pathway uses only three substrates (toluene, benzene and ethylbenzene), TodS/TodT mediates the regulation of P todX activity in response to a wide range of different aromatic compounds, including different methyl-, amino-, nitro-and halogen-substituted benzene and toluene derivatives (Lacal et al., 2006) . The TodS SK is unusually large (108 kDa) and composed of the following seven domains ( Fig. 1) : PAS sensor 1, DHp 1, CA 1, receiver, PAS sensor 2, DHp2 and CA 2. Effector molecules like toluene bind to the N-terminal PAS domain, which stimulates the kinase activity of the N-terminal AK module (Busch et al., 2009 ). The phosphoryl group is then transferred to Asp500 of the receiver domain and subsequently to the C-terminal AK module (Fig. 1) . The phosphoryl group then passes from His760 of TodS to Asp57 of the TodT RR (Busch et al., 2009) . We have shown that TodT binds to five different sites at P todX in a sequential and cooperative manner (Lacal et al., 2008a,b) . In addition, we have demonstrated that the activity of TodS/TodT is mediated by agonists and antagonists (Busch et al., 2007) . Both classes of compounds compete for binding at the PAS sensor 1 domain, but only agonists cause an increase in the TodS phosphorylation state. Owing to their competition for binding, the presence of antagonists reduces the magnitude of agonist-mediated upregulation of gene expression. Agonists and antagonists are structurally very similar (i.e. toluene and o-xylene, respectively) and are both present in mixtures such as petroleum. A major limitation in biodegradation consists in the insufficient induction of degradation pathway expression in bacteria exposed to complex mixtures (Cases and de Lorenzo, 2005) . The data presented (Busch et al., 2007) are consistent with the notion that the action of antagonists might be at least partially responsible for this reduced pathway induction. The TodS/ TodT system is the best-characterised member of a protein family. Other family members are the TCSs StyS/StyR (Velasco et al., 1998; Leoni et al., 2003) , TutC/TutB (Coschigano and Young, 1997) and TmoS/TmoT (Ramos-González et al., 2002) , which are all involved in the regulation of degradation pathways. In all cases the SKs share the same domain arrangement as TodS.
There is now evidence that phosphorelay TCSs have evolved from a fusion of prototype TCSs (Zhang and Shi, 2005; Whitworth and Cock, 2009 ). The fusion of prototype TCS to phosphorelay TCSs was found to be a continuous evolutionary process. Phosphorelay systems can be found in most of the phylogenetic clades of TCS and are present in one-third of bacterial genomes (Zhang and Shi, 2005; Whitworth and Cock, 2009 ). The physiological role of phosphorelay TCSs is still unclear but it was suggested that a modulation of the additional phosphorylation steps might offer the possibility of integrating additional environmental stimuli leading to a fine tuning of the final response (Burbulys et al., 1991) . Lau et al. (1997) have suggested that one reason for the complexity of TodS consists in the capacity to integrate additional signals. Based on a weak sequence similarity of the PAS2 domain with the FixL sensor domain the authors proposed that TodS might be able to sense oxygen. However, so far no evidence which supports this hypothesis has been reported.
It remains poorly understood as to why some cellular functions are controlled by prototype systems whereas others by phosphorelay TCS. Based on the known mechanism of action of TodS, namely the fact that aromatic effectors bind to the PAS1 domain, that there is an intramolecular phosphorelay and that phosphorylation of TodT occurs exclusively from the AK2 module, we have constructed a minimal version of TodS, termed as Min-TodS (Fig. 1) , which possesses only three of the seven TodS domains and which can be considered as a prototypal SK. Min-TodS was found to form a TCS with TodT that is capable of regulating expression from P todX in response to agonists. Different in vitro and in vivo analyses, however, revealed that the Min-TodS/TodT system differs from the TodS/TodT system in a number of features.
Materials and methods

Strains and plasmids
The strains and plasmids used in this study are listed in Table I .
Construction of plasmids containing min-todS
Plasmids pMIR66-Min-TodS and pET28b-Min-TodS were constructed for b-galactosidase measurements and protein expression, respectively. The gene coding for Min-TodS was constructed by three different polymerase chain reactions (PCRs). The initial two PCR reactions were carried out using pMIR66 (Table I) as template, which contains the todS sequence cloned into the BamHI and NheI sites of the vector. The first PCR reaction (amplification of the N-terminal fragment of Min-TodS) involved an amplification of a fragment covering the BamHI restriction site of pMIR66 until the codon encoding amino acid 182 of TodS using primers PAS1f and PAS1r (Table II) . The latter primer contains an extension (shown in italics in Table II ) that is complementary to the sequence encoding amino acids 753-757; the initial sequence of the C-terminal fragment of Min-TodS. In a second PCR (amplification of the C-terminal fragment of Min-TodS) a fragment comprising amino acids 753-978 and covering the NheI site of plasmid pMIR66 was amplified using primers AK2f and AK2r. Both PCR products overlap by 15 nucleotides. A third PCR contained equimolar amounts of the first two PCR products as well as primers PAS1f and AK2r. This reaction produced a DNA fragment coding for Min-TodS flanked by extensions containing the BamHI and NheI restriction sites, which permitted cloning into pMIR66 linearised with the same enzymes. The resulting plasmid was named pMIR66-Min-TodS. 
Restriction sites are highlighted in bold. Complementary and overlapping regions in the construction of Min-TodS are shown in italics.
Conversion of phosphorelay into prototype TCS
A similar strategy was used to generate pET28b-MinTodS, except that primers PAS1f and AK2r were substituted by primers PAS1f-1 and AK2r-1 that contain NdeI and BamHI cloning sites, respectively, permitting cloning into pET28b(þ) (Novagen) linearised with the same enzymes. The resulting plasmid was named pET28b-Min-TodS. All plasmids constructed were verified by DNA sequencing of the insert and flanking regions. Protein expression from this plasmid gives rise to a fusion protein of Min-TodS flanked by the N-terminal sequence MGSSHHHHHHSSGLVPRGSH containing the histidine tag.
Construction of expression plasmids containing the individual PAS domains and the AK1 module
The following four expression plasmids were constructed containing the individual PAS domains or the AK1 modules: pET28b-PAS1long
(TodS amino acids 1 -146), pET28b-PAS1short (TodS amino acids 15-146), pET28b-PAS2 (TodS amino acids 609-729) and pET28b-AK1 (TodS amino acids 147 -449). In all cases the corresponding fragments were amplified by PCR using pMIR66 as the template. Primers were designed to introduce NdeI and BamHI restriction sites, which permits cloning of the resulting products into pET28b(þ) (Novagen) linearised with the same enzymes. The following primers were used for the PCR reactions: plasmid pET28b-PAS1long: PAS1longf and PAS1longr; plasmid pET28b-PAS1short: PAS1shortf and PAS1longr; plasmid pET28b-PAS2: PAS2f and PAS2r; plasmid pET28b-AK1: AK1f and AK1r. Protein expression from this plasmid gives rise to a fusion protein of each fragment flanked by an N-terminal sequence MGSSHHHHHHSSGLVPRGSH containing a histidine tag. All plasmids constructed were verified by DNA sequencing of the insert and flanking regions.
Overexpression and purification of min-TodS under non-denaturing conditions
Escherichia coli BL21 (DE3) was transformed with plasmid pET28b-Min-TodS. Cultures were grown in 2 l erlenmeyer flasks containing 500 ml of LB medium supplemented with 50 mg/ml kanamycin at 308C until an OD 660 of 0.6, at which point protein production was induced by adding 0.1 mM isopropyl-beta-D-thiogalactopyranoside. Growth was continued at 168C overnight prior to cell harvest by centrifugation at 10 000 Â g for 30 min. Cell pellets were resuspended in buffer A (20 mM Tris, 0.1 mM EDTA, 500 mM NaCl, 10 mM imidazole, 5 mM b-mercaptoethanol and 5% (vol/ vol) glycerol, pH 8.0) and broken using a French press at 1000 psi. After centrifugation at 20 000 Â g for 1 h, the supernatant was loaded onto a 5 ml HisTrap column (Amersham Bioscience), washed with 10 column volumes of buffer A and eluted with an imidazole gradient of 45-500 mM in buffer A. Fractions containing Min-TodS were dialysed against analysis buffer 50 mM Tris pH 7.5, 300 mM KCl, 2 mM MgCl 2 , 0.1 mM EDTA, 2 mM DTT and 10% (vol/vol) glycerol, for immediate analysis.
Purification of Min-TodS under denaturing conditions and protein refolding
Min-TodS was expressed and purified as described above, except that the both purification buffers were supplemented with 6 M Guanidine-HCl. Eluted protein was pooled, diluted to 0.2 mg/ml and dialysed against analysis buffer containing 2 M urea and subsequently against two changes of analysis buffer. Protein was then filtered and concentrated for immediate analysis.
Overexpression and purification of TodS, TodSD500A and TodT
TodS and TodS D500A were purified as described in Lacal et al. (2006) . TodT was expressed and purified as described in Lacal et al. (2008a) .
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) experiments were conducted using freshly purified protein and a VP-microcalorimeter (Microcal, Amherst, MA) at 258C. Protein was dialysed into analysis buffer (50 mM Tris-HCl, 300 mM KCl, 2 mM MgCl 2 , 2 mM DTT, 0.1 mM EDTA, 10% glycerol, pH 7.5) and placed into the sample cell. Typically, 5 -10 mM Min-TodS was titrated with 350-500 mM effector solutions. Since these compounds are volatile and hydrophobic, these solutions were made in glass vessels immediately before use. The mean enthalpies measured from the injection of effectors into the buffer were subtracted from raw titration data prior to data analysis with the MicroCal version of ORIGIN. Data were fitted with the 'One binding site model' of ORIGIN.
Autophosphorylation assay
Ten micromolar of TodS or Min-TodS in 50 mM Tris-HCl, pH 7.5, 300 mM KCl, mM MgCl 2 , 0.1 mM EDTA, 10% (vol/vol) glycerol, 2 mM DTT were incubated at 48C with 200 mM ATP containing 4 mCi [g 32 P]ATP in the absence or presence of 100 mM toluene. At time intervals, samples were taken, the reaction being stopped by the addition of 4 Â SDS sample buffer and then stored at 2208C. After the completion of the time course samples were analysed by SDS-PAGE using 10% (wt/vol) gels. Protein-associated radioactive phosphorylgroups were visualised on a phosphoimager.
Transphosphorylation assay
Duplicate samples of Min-TodS were autophosphorylated in the absence or presence of 100 mM toluene. This reaction was carried out in 50 mM Tris-HCl, pH 7.5, 300 mM KCl, mM MgCl 2 , 0.1 mM EDTA, 10% (vol/vol) glycerol and 2 mM DTT at 48C. The reaction volume was 10 ml and contained 10 mM of purified Min-TodS. Reactions were initiated by the addition of radio-labelled ATP (200 mM ATP containing 4 mCi [g 32 P]ATP). After 50 min of autophosphorylation 6 ml of 20 mM purified TodT was added to one of the duplicate samples, whereas the corresponding amount of buffer was added to the remaining sample. After 10 min, the reaction was stopped by adding 4 Â SDS sample buffer. Samples were then treated as detailed for the autophosphorylation assay. All manipulations were done rapidly and at 48C.
Dephosphorylation assay
For dephosphorylation experiments 10 mM of protein in the buffer used for autophosphorylation (see above) was incubated with 200 mM ATP containing 4 mCi [g-32 P-ATP] in the absence or presence of 100 mM toluene for 50 min. A 200-fold molar excess of unlabelled ATP was added, and samples were removed at time intervals to be treated in the same manner as described for the transphosphorylation assay.
b-Galactosidase measurements
Pseudomonas putida DOT-T1E DtodST bearing pMIR77 (containing a P todX ::lacZ fusion) and pMIR66 (containing todST) or pMIR66-Min-TodS (containing min-todST) were analysed in parallel. Cells were grown overnight in LB medium supplemented with 25 mg/ml kanamycin, 10 mg/ml tetracycline and 100 mg/ml gentamycin. Cultures were diluted 100 times with the same medium and the different compounds were provided in the gas phase or for the competition assays in the presence of various effector molecules ( Supplementary Fig. S4 ) were added to the medium at a concentration of 1 mM. When the cultures reached an OD 600 of 0.8 + 0.05, b-galactosidase activity was determined in permeabilised cells as described in Ramos-González et al. (2002) .
Results
The two PAS domains and AK modules of TodS belong to different subfamilies PAS domains are among the most frequent sensor domains in bacteria . According to Pfam, the superfamily of PAS domains can be divided into seven families, which are each identified by a hidden Markov model. TodS contains two domains that belong to the PAS superfamily. However, each domain belongs to a different family. The PAS1 domain is recognised by model PF08448 (which defines the PAS4 subfamily), whereas the PAS2 domain belongs to the family defined by PF00989 (which defines the PAS family). The fact that both domains belong to different families is also supported by a sequence alignment of both domains ( Supplementary Fig. S1 ), which reveals an amino acid identity of 14%. This value is close to the random sequence identity obtained by the alignment of unrelated proteins (Doolittle, 1981) .
The histidine protein kinases also form a superfamily that can be divided into 11 different families (Grebe and Stock, 1999) . As reported in Busch et al. (2009) the N-terminal AK module of TodS belongs to the subfamily HPK1a whereas the C-terminal module forms part of the HPK4 family. In analogy to the PAS domains the sequence alignment of both AK modules also reveals a low degree of sequence identity of 22% (Supplementary Fig. S1 ). These results are consistent with the notion that TodS is the result of a gene fusion event of two TCSs rather than gene duplication.
Design and purification of Min-TodS
We have provided evidence that effectors bind solely to the N-terminal PAS domain of TodS, that this binding stimulates exclusively the N-terminal AK module and that TodT transphosphorylation occurs only from the C-terminal AK module (Busch et al., 2009) . These observations form the basis for the design of a minimal version of TodS (Min-TodS) that is composed of the PAS1 and the AK2 module (Fig. 1) . Min-TodS was constructed by fusing amino acids 1 -182 of the full-length TodS (containing the PAS1 domain and a 24 amino acid linker) with amino acids 753 -978 (see Materials and methods). A central fragment of 570 amino acids was thus removed from TodS. Min-TodS consists of 408 amino acids and has a molecular weight of 44.8 kDa. The coding sequence of Min-TodS was cloned into the expression vector pET28 and the protein was expressed in E.coli. Min-TodS was purified from the soluble fraction of the E.coli lysate by affinity chromatography. Purified Min-TodS was subjected to a number of analyses, which were conducted using the experimental conditions that were used to study the TodS/ TodT system (Lacal et al., 2006; Busch et al., 2007 Busch et al., , 2009 ).
TodS agonists and antagonists bind with high affinity to Min-TodS
As mentioned above, TodS recognises molecules that exert either an agonistic or antagonistic action (Busch et al., 2007) . Consequently, our experiments were aimed at establishing whether Min-TodS has conserved its capacity to bind TodS effector molecules. To this end the binding of TodS agonists and antagonists to Min-TodS was studied by ITC (Krell, 2008) . Figure 2 shows the microcalorimetric titration of buffer and Min-TodS with toluene. In the case of the buffer control, small and uniform peaks are observed, which are entirely due to dilution effects. In contrast, titration of Min-TodS with toluene generates exothermic heat signals that are reduced in size as protein saturation with ligand advances. Analysis of these data reveals that toluene binds to Min-TodS with a dissociation constant of 1.5 + 0.1 mM in a process driven by favourable enthalpy changes (211.0 + 0.5 kcal/mol) and counterbalanced by unfavourable entropy changes (TDS ¼ 23.0 + 0.5 kcal/mol). This dissociation Upper panel: raw titration data for the injection of a single 1.6 ml and a series of 3.2 ml aliquots of 500 mM toluene into buffer (A) and 6 mM Min-TodS (B). Lower panel: integrated and dilution-corrected raw data for the titration of Min-TodS that were normalised with the ligand concentration. Data were fitted with the 'One Binding site' model of the MicroCal version of ORIGIN.
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constant is thus comparable with that measured for TodS, which was of 0.68 + 0.02 mM (Lacal et al., 2006) .
Subsequently, Min-TodS was titrated with four TodS agonists (benzene, ethylbenzene, p-xylene and m-chlorotoluene) and two antagonists (o-xylene, o-chlorotoluene). All these compounds were found to bind to Min-TodS and the derived thermodynamic parameters are summarised in Table III. Affinities range from 270 nM in the case of m-chlorotoluene to 2.8 mM for o-chlorotoluene. With the exception of m-chlorotoluene, which binds 30 times tighter to Min-TodS as compared with TodS, the effector affinities for Min-TodS are comparable with those obtained for TodS (last column in Table III ). In addition, binding of 1,3,5-trimethylbenzene (1,3,5-TMB) was studied. This compound, although structurally similar to the other effector molecules tested, was found to interact with TodS with a high dissociation constant of 133 + 22 mM, which corresponds to the highest dissociation constant of any TodS ligand analysed (Busch et al., 2007) . Similarly, 1,3,5-TMB failed to bind to Min-TodS (not shown). These data show that Min-TodS has largely preserved its capacity to bind TodS agonists and antagonists with high affinity.
TodS agonists and antagonists reduce Min-TodS AK activity
We then investigated the influence of TodS agonists and antagonists on the AK activity. Toluene is one of the three TOD pathway substrates and the most potent inducer of tod operon expression in vivo (Lacal et al., 2006) . In the case of TodS the presence of saturating concentrations of toluene increased the phosphorylation state of the protein by a factor of 5 (Fig. 3, Lacal et al., 2006) . However, this stimulation of AK activity observed might account only partially for the 50-fold increase in gene expression (Lacal et al., 2006) . Min-TodS was subjected to autophosphorylation assays. The basal phosphorylation activity (in the absence of toluene) of Min-TodS was largely superior to the basal phosphorylation of TodS (Fig. 3) . However, the addition of toluene to Min-TodS resulted in a reduction of the phosphorylation state of the protein by 30-40% (Fig. 3) . This experiment was then repeated in the presence of two other TodS agonists (benzene and m-chlorotoluene) as well as with two antagonists (o-xylene and o-chlorotoluene). As shown in Fig. 3 , all of these compounds caused a reduction in the phosphorylation state of TodS. However, this reduction was less pronounced in the presence of agonists than antagonists (Fig. 3) . This suggests that agonists and antagonists have a differential effect on Min-TodS autophosphorylation. Compared with the effect on TodS the regulatory effect of agonists and antagonists on Min-TodS appears to be off-set into the negative range. To explain the unexpectedly high phosphorylation state of Min-TodS in the absence of effectors, we hypothesised that tightly binding signal molecules might co-purify with Min-TodS, causing this elevated autophosphorylation in the absence of toluene. To this end Min-TodS was purified under denaturing conditions and then refolded (for further detail see Materials and methods). Autophosphorylation assays with refolded protein and with protein purified under non-denaturing conditions were conducted in parallel. These assays reveal an almost identical level of autophosphorylation in the absence of toluene and a similar decrease in autophosphorylation in the presence of the above effectors (not shown). These data show that the elevated basal autophosphorylation level and the reduction in protein phosphorylation in the presence of effectors is an internal property of Min-TodS.
Min-TodS forms a TCS with TodT and mediates an increase in the amount of phosphorylated TodT in response to toluene
We have shown previously that the phosphorylated form of TodT stimulates expression from P todX (Lacal et al., 2006) . Central to the study of Min-TodS was to establish whether it forms a TCS with TodT and whether it maintains the capacity to modulate the amount of phosphorylated TodT in response to agonists. To this end Min-TodS and TodT were purified and subjected to transphosphorylation studies in the presence and absence of toluene (Fig. 4) . These assays involved the exposure of proteins to [g 32 P] ATP for 10 min, followed by an electrophoretic separation by SDS-PAGE and autoradiographic detection of protein-associated 32 P, indicative of the amount of protein phosphorylation. As shown in lane 1 of Fig. 4 , exposure of Min-TodS to ATP resulted in a strong band indicative of efficient autophosphorylation of the protein in the absence of toluene. When this experiment is repeated in the presence of TodT, the band corresponding to Min-TodS is significantly reduced, which is consistent with a transphosphorylation to TodT. However, no phosphorylated TodT could be visualised, which is partly due to the reduced phosphorylation half-life of TodT. The addition of toluene caused a slight reduction in the The effect of these compounds on TodS activity has been described in Busch et al. (2007). b Dissociation constants for TodS are taken from Busch et al. (2007) . phosphorylation state of Min-TodS (lane 3 in Fig. 4) . However, when all three components, Min-TodS, TodT and toluene, are present in the reaction mixture, a strong band at the level of Min-TodS is observed indicative of sustained autophosphorylation. Most importantly, a band representing phosphorylated TodT is clearly visible (Fig. 4, lane 4) . The intensity of this band was comparable with the corresponding band in the TodS -TodT transphosphorylation assays as reported earlier (Lacal et al., 2006) . From these experiments it can be concluded that Min-TodS has preserved its capacity to recognise and phosphorylate TodT and to mediate an increase of TodT-P in response to toluene.
Phosphorylation half-life of Min-TodS is significantly increased compared to TodS
A characteristic feature of a SK is its phosphorylation halflife. We have reported previously (Lacal et al., 2006) 
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subsequently a 200-fold excess of unlabelled ATP is added to dilute out radioactive ATP and samples are taken at time intervals. Phosphorylation at Min-TodS was remarkably stable and only an 15% decrease in phosphorylation was observed after 6 h of incubation (Fig. 5) . This indicates that the phosphorylation half-life of Min-TodS is much higher than that of TodS.
TodS operates by a phosphorelay involving His190 -Asp500 and His760 of TodS and Asp57 of TodT (Busch et al., 2009) . We hypothesised that the absence of the RR receiver (RRR) domain (harbouring Asp500) in Min-TodS might be the reason for this increased half-life. To this end, dephosphorylation experiments with the TodS mutant D500A were conducted (Fig. 5) . The phosphorylation halflife of this mutant was comparable with that of Min-TodS since phosphorylation decreased by 30% after 6 h. This indicates that the hydrolysis of the acylphosphate at Asp500 is the primary cause for the comparatively low phosphorylation half-life of TodS, which explains the stability of Min-TodS-P.
The individual PAS domains and AK modules cannot be obtained as structured, recombinant proteins Subsequent studies were aimed at producing the two PAS domains and the AK1 modules as recombinant proteins and to study their mutual interaction by calorimetry as well as to study effector binding to the individual PAS1 domain. To this end the coding sequence for the PAS1 and PAS2 domains as well as for the AK1 module were cloned into the expression vector pET28 and the resulting plasmid were introduced into several E.coli strains for overexpression (see Materials and methods). Despite the use of various E.coli strains and a wide range of expression conditions no protein expression was observed in the case of PAS1 and AK1. In the case of PAS2, a significant amount of pure protein was obtained. However, a 10-1298C upscan using differential scanning calorimetry (Krell, 2008) did not show any unfolding transitions (data not shown), indicating that the protein was unstructured. This conclusion is supported by the absence of secondary structure elements as revealed by far UV circular dichroism spectroscopy (data not shown). These data are consistent with the idea that the individual domains are thermodynamically unstable and do not permit further analyses.
Min-TodS modulates expression from P todX in response to effector molecules
To complement data obtained by in vitro experimentation, we have analysed the capacity of the Min-TodS/TodT TCS to modulate gene expression from P todX . For these experiments plasmid pMIR66-Min-TodS was constructed. The parent plasmid pMIR66 corresponds to a pBBR1MCS-1 derivative that contains the todST genes (Ramos-González et al., 2002) . In plasmid pMIR66-Min-TodS the todS gene was replaced by the coding sequence of Min-TodS. The plasmid was introduced into P.putida DOT-T1E DtodST (Ramos-González et al., 2002) harbouring plasmid pMIR77 containing the P todX ::lacZ fusion. The resulting strain was used for b-galactosidase measurements in the presence and absence of effector molecules. In the absence of effector molecules, a b-galactosidase activity of 900 Miller Units (MU) was measured. Subsequently, the responses to four TodS agonists (toluene, benzene, m-chlorotoluene and p-xylene), two TodS antagonists (o-xylene and o-chlorotoluene) and a structurally related compound that does not bind to Min-TodS (1,3,5-TMB) were determined (Fig. 6A) . The two TOD pathway substrates toluene and benzene stimulated P todX expression by factors of 4 and 2.5, respectively. A slight, but reproducible, increase in promoter activity was also observed for m-, o-chlorotoluene and p-xylene. It should be noted that toluene was found to be the most potent effector in the TodS-mediated increase in P todX expression (Lacal et al., 2006) . Finally, no significant increase in gene expression was observed in the presence of 1,3,5-TMB. This is not surprising since we have shown Fig. 6 . Expression from P todX mediated by Min-TodS/TodT (A) and TodS/ TodT (B) in response to different effector molecules. b-Galactosidase measurements of P.putida DOT-T1E DtodST harbouring plasmids pMIR77 and pMIR66-Min-TodS (A) or pMIR77 and pMIR66 (B). Plasmid pMIR66 harbours full-length TodS whereas pMIR66-Min-TodS harbours Min-TodS. Plasmid pMIR77 contains a fusion of promoter P todX with the lacZ gene. Data are the means and corresponding standard errors derived from at least three independent assays, each done in triplicate.
above that it does not bind to Min-TodS. This is initial evidence that the modulation of gene expression is modulated by Min-TodS/TodT and not due to any potential pleiotropic effects on gene expression that might have been caused by the addition of these toxic aromatic compounds to the bacterial culture. These measurements were taken at an OD of 0.8. We have then analysed promoter expression at ODs of 0.5 and 1.2, which showed similar results ( Supplementary Fig. S2 ).
To entirely exclude the possibility that upregulation observed is mediated by potential alternative mechanisms, b-galactosidase measurements were made using P.putida DOT-T1E DtodST harbouring only pMIR77 (containing P todX ::lacZ) but lacking pMIR66-Min-TodS (encoding the Min-TodS/TodT). The addition of toluene did not cause any significant modulation of gene expression providing evidence that gene upregulation reported above is mediated by Min-TodS/TodT (data not shown). In a second control experiment plasmid pJLC1 containing the todT gene was transferred into P.putida DOT-T1E DtodST harbouring only pMIR77. Promoter expression studies were conducted in the absence of effector and in presence of toluene, m-chlorotoluene and o-chlorotoluene. In all cases, obtained activities were indistinguishable and close to zero ( Supplementary Fig. S3 ). This indicates that promoter activity observed is mediated by Min-TodS and is not due to a secondary effect and also suggests that there is no additional path to phosphorylate TodT. P todX expression studies by the TodS/TodT system were performed previously (Lacal et al., 2006) , but using a different experimental strategy as compared with this study. In the initial study, P.putida DOT-T1E bearing pMIR77 was used and TodS and TodT were of genomic origin. In the present study the P.putida DOT-T1E mutant strain DtodST was used and Min-TodS/TodT were encoded by the medium copy number plasmid pMIR66-Min-TodS. To compare the magnitude of promoter activity of the TodS/TodT TCS with the Min-TodS/TodT system, b-galactosidase measurements of P.putida DOT-T1E DtodST containing pMIR77 and pMIR66 (harbouring todST) were conducted (Fig. 6B) . In the absence of effector molecules, a basal activity of 50 MU was observed and the addition of toluene resulted in an activity of 12 300 MU, which corresponds to an increase by a factor of 250. In agreement with the published data, the three remaining agonists benzene, m-chlorotoluene and p-xylene induced an activity of 3000 -8000 MU whereas the values for the antagonists o-xylene and o-chlorotoluene were comparable with the control.
The last set of experiments involved expression experiments with multiple effector molecules. In the experiments so far reported, the effector molecules were provided in the gas phase. The competition experiments have been conducted using a protocol similar to that described by Busch et al. (2007) in which effectors were added directly to the growth medium in order to precisely control its concentrations. As shown in Supplementary Fig. S4 toluene was the most potent inducer followed by o-chlorotoluene and m-chlorotoluene. The difference in the potency of both effectors was also reflected when they were added to toluenecontaining samples (for experimental details please refer to the legend of Supplementary Fig. S4 ). Promoter activities in the presence of toluene and o-chlorotoluene were comparable with that in the presence of toluene alone. However, a mixture of m-chlorotoluene with toluene caused a reduction in promoter expression as compared with the toluene sample. These data are consistent with the notion that effectors share the same binding site at Min-TodS.
Discussion
Bacterial signal transduction is mediated primarily by the concerted action of several protein families, namely TCSs, one-component systems, methylaccepting chemotaxis proteins, serine/threonine kinases, adenylate and guanylate cyclases and phosphodiesterases (Galperin, 2005; . These protein families are characterised by a modular arrangement containing input (sensing) and output domains. Interestingly, protein families share the same type of sensor modules. For example, the PAS (Möglich et al., 2009b) and TarH domains were found to be present in many different protein families. This indicates that during evolution sensor domains have been recombined with other output modules.
This evolutionary evidence is also supported by experimental data and there are several reports on the recombination of sensor domains with output modules of different proteins. The chimeric Taz protein is a fusion of the TarH-type sensor domain of the Tar chemoreceptor with the AK module of EnvZ. The Tar chemoreceptor mediates a chemotactic response towards aspartate whereas the EnvZ/ OmpR system controls the expression of genes encoding porins. It was shown that the Taz/OmpR system controls porin expression in response to aspartate (Utsumi et al., 1989) . The Moffat group has constructed various chimeric proteins based on the photosensor YtvA and the FixL SK. YtvA has a single PAS domain that senses blue light, whereas FixL has two PAS domains, of which one (PAS A) is of unknown function whereas the other (PAS B) senses oxygen. A FixL derivative in which both PAS domains (Möglich et al., 2009a) or the PAS A domain (Möglich et al., 2010) are replaced by the YtvA sensor domain, was found to be active and to mediate responses to blue light.
To our knowledge, our study corresponds to the first construction of a prototypal SK using elements of a phosphorelay kinase. Our data confirm the apparent ease by which sensor domains can be recombined with different output modules. The comparison of TodS/TodT with Min TodS/TodT has revealed several issues. Firstly, TodS and Min-TodS recognise effector molecules with similar affinity (Table III) . In addition, for both proteins effector molecules can be classified into agonists and antagonists (Fig. 6 ). These data indicate that the molecular determinants for effector recognition and their either agonistic or antagonistic action are located in the PAS1 domain. This conclusion is consistent with our proposition (Busch et al., 2007) that the agonistic or antagonistic action of effector molecules may be caused by two different modes of ligand binding to the PAS1 domain.
Secondly, significant differences in the phosphorylation half-lifes of TodS and Min-TodS were observed. For TodS a phosphorylation half-life of 71 min was determined (Lacal et al., 2006) , whereas the phosphorylated form of Min-TodS was stable over at least 6 h, indicating a significant increase in its phosphorylation half-life (Fig. 5) . Experiments with the Conversion of phosphorelay into prototype TCS TodS mutant D500A demonstrated that the hydrolysis of the acylphosphate at the aspartate residue of the TodS receiver domain is the primary cause for the comparatively low halflife of TodS-P. It can thus be concluded that the differences in half-lives enable the TodS/TodT system to return faster to the non-activated state than its prototypal derivative. This rapidity of reaction could be an advantage in the context of environmental changes that involve a sudden absence of aromatic hydrocarbons.
Thirdly, there were differences at the basal activities of promoter expression. Promoter P todX was almost silent (50 MU) in the native TodS system, whereas a basal activity of 900 MU was observed for the Min-TodS system. We have shown previously (Busch et al., 2009) that TodS mutants in which the phosphorylaccepting amino acids H190, D500 and H760 are replaced by alanine, possess a low basal AK activity that is comparable with the wild-type protein. As a result promoter activities are very low in the absence of effectors. This demonstrates that the low basal activity occurs irrespective of there being a functional phosphorelay. However, the removal of the central AK1-RRR-PAS2 fragment causes an increase in the basal promoter activity. We hypothesise that intra-TodS contacts between the AK1-RRR-PAS2 fragment with the remaining protein might cause this reduction in basal activity. This very low basal activity of the TodS system is advantageous compared to the Min-TodS system since the TOD pathway acts exclusively on three substrates and the tod operon expression in the absence of these compounds is a futile event.
Fourthly, the magnitude of gene expression mediated by toluene and benzene, the two primary pathway substrates, was significantly higher for the phosphorelay system as compared with its prototypal derivative. For example, the TodS/ TodT-mediated gene expression was of 12 000 and 8000 MU for toluene and benzene, respectively, whereas the corresponding values for the Min-TodS/TodT system were of 3500 and 2000 MU. Since the phosphorylated form of TodT can be associated with the increase in gene expression, it can be suggested that the amount of TodT-P generated by the action of TodS is superior to that generated by Min-TodS.
Fifthly, despite the very-low-sequence identity between the PAS1 and PAS2 domains and the AK1 and AK2 modules of TodS, the successful construction of Min-TodS underlines that PAS sensor domains and AK modules can be recombined with apparent ease. To understand this apparent plasticity in domain interaction, the 3D structure of the ThkA SK (Yamada et al., 2009) can provide potential reasons. The cytosolic ThkA is composed of a PAS domain followed in sequence by an AK module, which corresponds to the Min-TodS domain organisation. This structure reveals details of the PAS domain -AK module interaction ( Supplementary Fig. S5 ). The surface of domain interaction is surprisingly small and restricted to a simple interaction between strand b3 of the PAS b-sheet and strand b6 of the catalytic domain of the AK module, which creates an interdomain b-sheet. Interestingly, the interdomain b-sheet is mediated exclusively by main chain interactions. It is likely that the domain communication between the two domains in Min-TodS occurs in a similar manner as in ThkA. The fact that the area of interaction between both domains is minimal and that this interaction is mediated by main chain atoms might indicate that there is only a modest evolutionary pressure on both domains to conserve amino acids involved in interaction.
Sixthly, toluene causes in both systems an increase in the concentration of TodT-P (Lacal et al., 2006, Fig. 4) . However, in the case of TodS toluene was found to stimulate its AK activity (Lacal et al., 2006) , whereas the exposure of Min-TodS to toluene caused a slight reduction in its AK activity (Fig. 3) . To explain this apparent discrepancy we would like to refer to a survey of TCS, which has revealed that the large part of SKs is bifunctional proteins that possess both kinase and phosphatase activities towards its RR (Huynh and Stewart, 2011) . It was suggested that the kinase active and the phosphatase active states of a SK correspond to two mutually exclusive conformations of the SK transmitter module, which implies a reciprocal character of both activities associated (Stewart, 2010) . Both SK conformations are thought to be present in equilibrium and the stimulus resulting from signal molecule recognition is thought to shift this equilibrium between both conformations to one or the other side (Huynh and Stewart, 2011) . In analogy to this general model for bifunctional SKs, we propose that toluene increases TodS AK activity and at the same time reduces its phosphatase activity towards TodT. In Min-TodS the capacity to upregulate its AK activity in response to toluene has been eliminated and the regulatory effect of the Min-TodS/TodT system is therefore likely due to the regulation of its phosphatase activity. However, all attempts to characterise TodS or Min-TodS phosphatase activities were unsuccessful.
In summary, the reduced basal activity, the larger magnitude of gene induction in response to toluene as well as the reduced half-life of phosphorylated TodS as compared with Min-TodS appear to be features which make the phosphorelay system better suited to regulate expression of a degradation pathway of toxic compounds.
Supplementary data
Supplementary data are available at PEDS online.
